Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology/Plastic Surgery | Rheumatology | Neurology
Disease Category: Scleroderma
Trial Information
Scleroderma - Adults
Adults with Scleroderma are asked to participate in a research study being conducted by North Shore Long Island Jewish Health System.
You may be eligible to participate in this study if you:
- Are 18 years of age
- Diagnosed with systemic sclerosis (effects joints and organs of the body)
- Have at least moderate skin thickening in at least one area able to have repeat biopsies (such as arms, legs, or trunk)
- Are willing not to have other experimental treatment during study
You may not participate in this study if you:
- Have a history of allergy or reaction to any component of the study drug (MEDI-546) formulation
- Have Herpes zoster infection within 3 months before study start
- Have been vaccinated with live attenuated viruses (e.g. chickenpox, measles) within 28 days before study start
- Have a history of immune system illness
- ยท Have tuberculosis (TB) infection without completion of an appropriate course of treatment
Rachel Saltzman, Study Coordinator
Biomedical Research Alliance of New York
North Shore Long Island Jewish Health System
2800 Marcus Avenue, Suite 200
Lake Success, NY 11042
Phone: 516-708-2559
Fax: 516-708-2574
EMail: rsaltzma@nshs.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
